Pancreatic Stellate Cells
"Pancreatic Stellate Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Star-shaped, myofibroblast-like cells located in the periacinar, perivascular, and periductal regions of the EXOCRINE PANCREAS. They play a key role in the pathobiology of FIBROSIS; PANCREATITIS; and PANCREATIC CANCER.
| Descriptor ID |
D058954
|
| MeSH Number(s) |
A11.700
|
| Concept/Terms |
Pancreatic Stellate Cells- Pancreatic Stellate Cells
- Cell, Pancreatic Stellate
- Cells, Pancreatic Stellate
- Pancreatic Stellate Cell
- Stellate Cell, Pancreatic
- Stellate Cells, Pancreatic
|
Below are MeSH descriptors whose meaning is more general than "Pancreatic Stellate Cells".
Below are MeSH descriptors whose meaning is more specific than "Pancreatic Stellate Cells".
This graph shows the total number of publications written about "Pancreatic Stellate Cells" by people in this website by year, and whether "Pancreatic Stellate Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pancreatic Stellate Cells" by people in Profiles.
-
Pancreatic stellate cells and the interleukin family: Linking fibrosis and immunity to pancreatic ductal adenocarcinoma (Review). Mol Med Rep. 2024 09; 30(3).
-
Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. Int J Mol Sci. 2023 Sep 27; 24(19).
-
A comparative Proteomics Analysis Identified Differentially Expressed Proteins in Pancreatic Cancer-Associated Stellate Cell Small Extracellular Vesicles. Mol Cell Proteomics. 2022 12; 21(12):100438.
-
ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1?/NF-?B/ESE3 signalling axis. Br J Cancer. 2022 11; 127(8):1461-1472.
-
Role of stromal activin A in human pancreatic cancer and metastasis in mice. Sci Rep. 2021 04 12; 11(1):7986.
-
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Gut. 2022 02; 71(2):357-371.
-
Type I collagen deletion in aSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell. 2021 04 12; 39(4):548-565.e6.
-
Stellate Cells in the Tumor Microenvironment. Adv Exp Med Biol. 2020; 1263:67-84.
-
A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression. Cancer Discov. 2019 05; 9(5):617-627.
-
Development of photoactive Sweet-C60 for pancreatic cancer stellate cell therapy. Nanomedicine (Lond). 2018 12; 13(23):2981-2993.